Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP222617.RAjnqS9pMa6LU0U_4msTGOFxrtF7Eq2SSa-BtsHZ66ZFA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP222617.RAjnqS9pMa6LU0U_4msTGOFxrtF7Eq2SSa-BtsHZ66ZFA130_assertion type Assertion NP222617.RAjnqS9pMa6LU0U_4msTGOFxrtF7Eq2SSa-BtsHZ66ZFA130_head.
- NP222617.RAjnqS9pMa6LU0U_4msTGOFxrtF7Eq2SSa-BtsHZ66ZFA130_assertion description "[ADA expression from these vectors was monitored in the ADA- human histiocytic lymphoma cell line DHL-9, and in the multipotential chronic myeloid leukemia cell line K562.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP222617.RAjnqS9pMa6LU0U_4msTGOFxrtF7Eq2SSa-BtsHZ66ZFA130_provenance.
- NP222617.RAjnqS9pMa6LU0U_4msTGOFxrtF7Eq2SSa-BtsHZ66ZFA130_assertion evidence source_evidence_literature NP222617.RAjnqS9pMa6LU0U_4msTGOFxrtF7Eq2SSa-BtsHZ66ZFA130_provenance.
- NP222617.RAjnqS9pMa6LU0U_4msTGOFxrtF7Eq2SSa-BtsHZ66ZFA130_assertion SIO_000772 2752148 NP222617.RAjnqS9pMa6LU0U_4msTGOFxrtF7Eq2SSa-BtsHZ66ZFA130_provenance.
- NP222617.RAjnqS9pMa6LU0U_4msTGOFxrtF7Eq2SSa-BtsHZ66ZFA130_assertion wasDerivedFrom befree-20150227 NP222617.RAjnqS9pMa6LU0U_4msTGOFxrtF7Eq2SSa-BtsHZ66ZFA130_provenance.
- NP222617.RAjnqS9pMa6LU0U_4msTGOFxrtF7Eq2SSa-BtsHZ66ZFA130_assertion wasGeneratedBy ECO_0000203 NP222617.RAjnqS9pMa6LU0U_4msTGOFxrtF7Eq2SSa-BtsHZ66ZFA130_provenance.